osteoporosis
3 articles tagged with ‘osteoporosis’
Peptides That Improve Bone Mineral Density: Osteoporosis Research Review
Research review of peptides investigated for bone mineral density in osteoporosis models, including preclinical evidence and limitations.
Teriparatide: Rebuilds Bones and Cuts Osteoporosis Fractures
Teriparatide, a synthetic peptide mimicking parathyroid hormone, stimulates new bone formation to combat osteoporosis. Clinical trials show it reduces new vertebral fractures by 65% and boosts bone mineral density significantly. Approved by the FDA in 2002, it offers a unique anabolic approach for high-risk patients.
.jpg)
Abaloparatide Reduces Osteoporotic Spine Fractures by 84%
Abaloparatide, an analog of human PTHrP (1-34), shows strong potential in treating osteoporosis by boosting bone formation while limiting resorption. Animal studies confirm its ability to reverse bone loss in ovariectomy models, and a phase 3 trial revealed an 84% lower risk of new spine fractures at 43 months compared to placebo. This peptide offers advantages over traditional antiresorptives by improving bone strength and density.